Skip to main content

Animations

MJFF Publications

2401 - 2410 of 6514 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2021
  • 2023
  • Summary Details
    OPEN
    Title: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease: Cross-over single-blinded study and long-term follow-up
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.010
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.017
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The East Asian Parkinson Disease Genomics Consortium
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00373-2
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Intracellular Thermometry to Study Protein Aggregation Related to Neurodegenerative Diseases
    Journal Name: Trends in Biochemical Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.tibs.2020.12.003
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Closing the structure-to-function gap for LRRK2
    Journal Name: Trends in Biochemical Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.tibs.2021.10.003
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study
    Journal Name: Neuroimage: Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ynirp.2021.100026
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Protein network analysis links the NSL complex to Parkinson’s disease via mitochondrial and nuclear biology
    Journal Name: Molecular Omics
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1039/d2mo00325b
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.